219 related articles for article (PubMed ID: 30792262)
41. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
Shen SN; Wang LF; Jia YF; Hao YQ; Zhang L; Wang H
Diagn Pathol; 2013 Apr; 8():69. PubMed ID: 23631806
[TBL] [Abstract][Full Text] [Related]
42. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
43. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
[TBL] [Abstract][Full Text] [Related]
44. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
45. High Expression of Stromal Cell-Derived Factor 1 (SDF-1) and NF-κB Predicts Poor Prognosis in Cervical Cancer.
Song Z; Zhang X; Ye X; Feng C; Yang G; Lu Y; Lin Y; Dong C
Med Sci Monit; 2017 Jan; 23():151-157. PubMed ID: 28074045
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
47. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
Zhang W; Hou T; Niu C; Song L; Zhang Y
PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
[TBL] [Abstract][Full Text] [Related]
48. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
[TBL] [Abstract][Full Text] [Related]
49. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
[TBL] [Abstract][Full Text] [Related]
50. Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
Wang Y; Li D; Liu Y; Tian S; Chen X
Pathol Res Pract; 2018 Sep; 214(9):1340-1344. PubMed ID: 30033330
[TBL] [Abstract][Full Text] [Related]
51. Up-regulation of ROR2 is associated with unfavorable prognosis and tumor progression in cervical cancer.
Sun B; Ye X; Lin L; Shen M; Jiang T
Int J Clin Exp Pathol; 2015; 8(1):856-61. PubMed ID: 25755786
[TBL] [Abstract][Full Text] [Related]
52. Expression of TRIM44 and its correlation with TLR4 in laryngeal squamous cell carcinoma.
Bai J; Liu X; Zhang S; Dang S; Zhang Y; Zhang G
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):56-61. PubMed ID: 36227676
[TBL] [Abstract][Full Text] [Related]
53. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW
Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741
[TBL] [Abstract][Full Text] [Related]
54. YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44.
Li W; Chen G; Feng Z; Zhu B; Zhou L; Zhang Y; Mai J; Jiang C; Zeng J
Genes Genomics; 2021 Dec; 43(12):1413-1421. PubMed ID: 34677810
[TBL] [Abstract][Full Text] [Related]
55.
Liu X; Guo R; Xu Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):463-470. PubMed ID: 34280008
[No Abstract] [Full Text] [Related]
56. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
[TBL] [Abstract][Full Text] [Related]
57. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
[TBL] [Abstract][Full Text] [Related]
58. P27 as a prognostic factor of early cervical carcinoma.
Bouda J; Hes O; Koprivova M; Pesek M; Svoboda T; Boudova L
Int J Gynecol Cancer; 2013 Jan; 23(1):164-9. PubMed ID: 23221604
[TBL] [Abstract][Full Text] [Related]
59. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
60. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]